123i ibzm

From Encyclopedia & World Directory

123i ibzm - a radiopharmaceutical containing the dopamine d2/d3 receptor agonist iodobenzamide (ibzm) labeled with the radionuclide iodine I 123 with dopamine receptor binding and radioisotopic activities. Upon administration, iodine I 123 iodobenzamide binds to dopamine d2/d3 receptors; subsequently, tissues expressing these receptors can be visualized using single photon emission computed tomography (spect). Dopamine receptors are a class of metabotropic g protein coupled receptors found in the central nervous system (cns) and neuroendocrine tumors such as pheochromocytoma and paraganglioma.

Latest research

External links[edit source]


Latest articles - 123i ibzm[edit source]

Clinical trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on 123i ibzm for any updates.

Navigation: Wellness - Health Encyclopedia - Health topics - Disease Index‏‎ - Cases - Drugs - Rare diseases - Gray's Anatomy - USMLE - All Pages

World directories: Doctors - Healthsites - Hospitals - Medical schools

WikiMD's articles are provided for informational purposes, and is not a substitute for professional medical advice. See full disclaimer.

Tired of being Overweight? Want to lose weight with insurance?
Try W8MD's physician weight loss - Philadelphia weight loss & NYC lose weight.